FDA Fires Vinay Prasad, Biotech Left Swiping Left
In this week's episode of 'The Readout LOUD,' STAT's sharp biotech reporters dissect the drama behind Vinay Prasad's ouster from the FDA, leaving the biotech world wondering if this is a plot twist or just another episode of regulatory Game of Thrones. As the show bluntly puts it, they 'parse what Vinay Prasad's ouster means for biotech and the FDA,' because nothing says biotech thrill like politics and power moves thicker than a monoclonal antibody cocktail.
Share the Story
(1 of 3)Vinay Prasad gets the boot and the biotech world collectively checks if FDA drama is now their new soap opera. Spoiler: No oneâs safe, and placebo effects are looking more like real ones.
Prasadâs exit proves biotech canât have nice things, especially when FDA offices feel more like reality TV voting circles. Whoâs nextâFrank Underwood with a lab coat?
FDA just threw Vinay Prasad out like last seasonâs leftover pipettes. Meanwhile, scientist emojis everywhere are loading their CRISPR guns for clout.
Source: Statnews | Published: 7/31/2025 | Author: Elaine Chen, Adam Feuerstein, and Matthew Herper
More Articles in Science
Man Applies to 200 Jobs with AI's Help, Still Does Own Eyerolling
Motorola Razr Flip Phones Finally Told Theyâre Secure Enough for 2027
KPMGâs Consulting Business Dies Dramatically While Staff Take a Hike
America Tries Staying Cool While Secretly Preparing For Wattocalypse
RAND Warns AI Bioweapons Might Become Netflix's Next Worst Series
Southern England Confuses Weather; Asks Where the Rain Went
AI Experts United: How to Accidentally Invent Killer Virus Before Lunch
Trump Admin Tries to Direct Mars Science Like a Reality Show Producer
